SrasV1, Main, Exploration, bibRecord, 002351

Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation

Identifieur interne : 002351 ( Main/Exploration ); précédent : 002350; suivant : 002352

Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation

Auteurs : Thi Thanh Hanh Nguyen [Corée du Sud] ; Hwa-Ja Ryu [Corée du Sud] ; Se-Hoon Lee [Corée du Sud] ; Soonwook Hwang [Corée du Sud] ; Vincent Breton [France] ; JOON HAENG RHEE [Corée du Sud] ; Doman Kim [Corée du Sud]

Source :

Bioorganic & medicinal chemistry letters : (Print) [ 0960-894X ] ; 2011.

RBID : Pascal:11-0474387

Descripteurs français

Pascal (Inist)
- Criblage virtuel, Inhibition compétitive, Antiviral, Cysteine endopeptidases, Inhibiteur enzyme, In vitro, Complexe enzyme inhibiteur, Spectrométrie fluorescence, Transfert énergie résonnant, Modèle moléculaire, Modélisation, Prédiction, Relation structure activité, Algorithme recherche, Algorithme génétique, Virus syndrome respiratoire aigu sévère, Dérivé du furane, Déhydroaminoacide, Carboxamide, Amine tertiaire, Composé nitro, Mode liaison, Bioinformatique, 2-Furyl-β-déshydroalaninamide(N-[2-(diméthylamino)propyl]-5-[2-nitrophényl]-Nα-p-toluoyl).

English descriptors

KwdEn :
- Antiviral, Binding mode, Bioinformatics, Carboxamide, Competitive inhibition, Cysteine endopeptidases, Dehydroaminoacid, Enzyme inhibitor, Fluorescence spectrometry, Furan derivatives, Genetic algorithm, In vitro, Inhibitor enzyme complex, Modeling, Molecular model, Nitro compound, Prediction, Resonant energy transfer, Search algorithm, Severe acute respiratory syndrome virus, Structure activity relation, Tertiary amine, Virtual screening.

Abstract

The 3C-like protease (3CL^pro) of severe acute respiratory syndrome associated coronavirus (SARS-CoV) is vital for SARS-CoV replication and is a promising drug target. Structure based virtual screening of 308 307 chemical compounds was performed using the computation tool Autodock 3.0.5 on a WISDOM Production Environment. The top 1468 ranked compounds with free binding energy ranging from -14.0 to -17.09 kcal mol^-1 were selected to check the hydrogen bond interaction with amino acid residues in the active site of 3CL^pro. Fifty-three compounds from 35 main groups were tested in an in vitro assay for inhibition of 3CL^pro expressed by Escherichia coli. Seven of the 53 compounds were selected; their IC₅₀ ranged from 38.57 ± 2.41 to 101.38 ± 3.27 μM. Two strong 3CL^pro inhibitors were further identified as competitive inhibitors of 3CL^pro with K_i values of 9.11 ± 1.6 and 9.93 ± 0.44 μM. Hydrophobic and hydrogen bond interactions of compound with amino acid residues in the active site of 3CL^pro were also identified.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 000087
to stream PascalFrancis, to step Curation: 000901
to stream PascalFrancis, to step Checkpoint: 000072
to stream Main, to step Merge: 002379
to stream Main, to step Curation: 002351

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation</title>
<author><name sortKey="Nguyen, Thi Thanh Hanh" sort="Nguyen, Thi Thanh Hanh" uniqKey="Nguyen T" first="Thi Thanh Hanh" last="Nguyen">Thi Thanh Hanh Nguyen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>School of Biological Sciences and Technology, Chonnam National University</s1>
<s2>Gwangju</s2>
<s3>KOR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
<wicri:noRegion>Gwangju</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ryu, Hwa Ja" sort="Ryu, Hwa Ja" uniqKey="Ryu H" first="Hwa-Ja" last="Ryu">Hwa-Ja Ryu</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>School of Biological Sciences and Technology and The Research Institute for Catalysis, Chonnam National University</s1>
<s3>KOR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
<wicri:noRegion>School of Biological Sciences and Technology and The Research Institute for Catalysis, Chonnam National University</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lee, Se Hoon" sort="Lee, Se Hoon" uniqKey="Lee S" first="Se-Hoon" last="Lee">Se-Hoon Lee</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Korea Institute of Science and Technology Information</s1>
<s2>Daejeon</s2>
<s3>KOR</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
<wicri:noRegion>Korea Institute of Science and Technology Information</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hwang, Soonwook" sort="Hwang, Soonwook" uniqKey="Hwang S" first="Soonwook" last="Hwang">Soonwook Hwang</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Korea Institute of Science and Technology Information</s1>
<s2>Daejeon</s2>
<s3>KOR</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
<wicri:noRegion>Korea Institute of Science and Technology Information</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Breton, Vincent" sort="Breton, Vincent" uniqKey="Breton V" first="Vincent" last="Breton">Vincent Breton</name>
<affiliation wicri:level="3"><inist:fA14 i1="04"><s1>LPC Clermont-Ferrand, Campus des Cézeaux</s1>
<s2>63177 Aubière</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Auvergne (région administrative)</region>
<settlement type="city">Aubière</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Joon Haeng Rhee" sort="Joon Haeng Rhee" uniqKey="Joon Haeng Rhee" last="Joon Haeng Rhee">JOON HAENG RHEE</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Chonnam National University Medical School and Clinical Vaccine RD Institute</s1>
<s2>Hwa-Sun</s2>
<s3>KOR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
<wicri:noRegion>Chonnam National University Medical School and Clinical Vaccine RD Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kim, Doman" sort="Kim, Doman" uniqKey="Kim D" first="Doman" last="Kim">Doman Kim</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>School of Biological Sciences and Technology, Chonnam National University</s1>
<s2>Gwangju</s2>
<s3>KOR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
<wicri:noRegion>Gwangju</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">11-0474387</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0474387 INIST</idno>
<idno type="RBID">Pascal:11-0474387</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000087</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000901</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000072</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000072</idno>
<idno type="wicri:doubleKey">0960-894X:2011:Nguyen T:virtual:screening:identification</idno>
<idno type="wicri:Area/Main/Merge">002379</idno>
<idno type="wicri:Area/Main/Curation">002351</idno>
<idno type="wicri:Area/Main/Exploration">002351</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation</title>
<author><name sortKey="Nguyen, Thi Thanh Hanh" sort="Nguyen, Thi Thanh Hanh" uniqKey="Nguyen T" first="Thi Thanh Hanh" last="Nguyen">Thi Thanh Hanh Nguyen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>School of Biological Sciences and Technology, Chonnam National University</s1>
<s2>Gwangju</s2>
<s3>KOR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
<wicri:noRegion>Gwangju</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ryu, Hwa Ja" sort="Ryu, Hwa Ja" uniqKey="Ryu H" first="Hwa-Ja" last="Ryu">Hwa-Ja Ryu</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>School of Biological Sciences and Technology and The Research Institute for Catalysis, Chonnam National University</s1>
<s3>KOR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
<wicri:noRegion>School of Biological Sciences and Technology and The Research Institute for Catalysis, Chonnam National University</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lee, Se Hoon" sort="Lee, Se Hoon" uniqKey="Lee S" first="Se-Hoon" last="Lee">Se-Hoon Lee</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Korea Institute of Science and Technology Information</s1>
<s2>Daejeon</s2>
<s3>KOR</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
<wicri:noRegion>Korea Institute of Science and Technology Information</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hwang, Soonwook" sort="Hwang, Soonwook" uniqKey="Hwang S" first="Soonwook" last="Hwang">Soonwook Hwang</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Korea Institute of Science and Technology Information</s1>
<s2>Daejeon</s2>
<s3>KOR</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
<wicri:noRegion>Korea Institute of Science and Technology Information</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Breton, Vincent" sort="Breton, Vincent" uniqKey="Breton V" first="Vincent" last="Breton">Vincent Breton</name>
<affiliation wicri:level="3"><inist:fA14 i1="04"><s1>LPC Clermont-Ferrand, Campus des Cézeaux</s1>
<s2>63177 Aubière</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Auvergne (région administrative)</region>
<settlement type="city">Aubière</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Joon Haeng Rhee" sort="Joon Haeng Rhee" uniqKey="Joon Haeng Rhee" last="Joon Haeng Rhee">JOON HAENG RHEE</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Chonnam National University Medical School and Clinical Vaccine RD Institute</s1>
<s2>Hwa-Sun</s2>
<s3>KOR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
<wicri:noRegion>Chonnam National University Medical School and Clinical Vaccine RD Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kim, Doman" sort="Kim, Doman" uniqKey="Kim D" first="Doman" last="Kim">Doman Kim</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>School of Biological Sciences and Technology, Chonnam National University</s1>
<s2>Gwangju</s2>
<s3>KOR</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
<wicri:noRegion>Gwangju</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Bioorganic & medicinal chemistry letters : (Print)</title>
<title level="j" type="abbreviated">Bioorg. med. chem. lett. : (Print)</title>
<idno type="ISSN">0960-894X</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Bioorganic & medicinal chemistry letters : (Print)</title>
<title level="j" type="abbreviated">Bioorg. med. chem. lett. : (Print)</title>
<idno type="ISSN">0960-894X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral</term>
<term>Binding mode</term>
<term>Bioinformatics</term>
<term>Carboxamide</term>
<term>Competitive inhibition</term>
<term>Cysteine endopeptidases</term>
<term>Dehydroaminoacid</term>
<term>Enzyme inhibitor</term>
<term>Fluorescence spectrometry</term>
<term>Furan derivatives</term>
<term>Genetic algorithm</term>
<term>In vitro</term>
<term>Inhibitor enzyme complex</term>
<term>Modeling</term>
<term>Molecular model</term>
<term>Nitro compound</term>
<term>Prediction</term>
<term>Resonant energy transfer</term>
<term>Search algorithm</term>
<term>Severe acute respiratory syndrome virus</term>
<term>Structure activity relation</term>
<term>Tertiary amine</term>
<term>Virtual screening</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Criblage virtuel</term>
<term>Inhibition compétitive</term>
<term>Antiviral</term>
<term>Cysteine endopeptidases</term>
<term>Inhibiteur enzyme</term>
<term>In vitro</term>
<term>Complexe enzyme inhibiteur</term>
<term>Spectrométrie fluorescence</term>
<term>Transfert énergie résonnant</term>
<term>Modèle moléculaire</term>
<term>Modélisation</term>
<term>Prédiction</term>
<term>Relation structure activité</term>
<term>Algorithme recherche</term>
<term>Algorithme génétique</term>
<term>Virus syndrome respiratoire aigu sévère</term>
<term>Dérivé du furane</term>
<term>Déhydroaminoacide</term>
<term>Carboxamide</term>
<term>Amine tertiaire</term>
<term>Composé nitro</term>
<term>Mode liaison</term>
<term>Bioinformatique</term>
<term>2-Furyl-β-déshydroalaninamide(N-[2-(diméthylamino)propyl]-5-[2-nitrophényl]-Nα-p-toluoyl)</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The 3C-like protease (3CL<sup>pro</sup>
) of severe acute respiratory syndrome associated coronavirus (SARS-CoV) is vital for SARS-CoV replication and is a promising drug target. Structure based virtual screening of 308 307 chemical compounds was performed using the computation tool Autodock 3.0.5 on a WISDOM Production Environment. The top 1468 ranked compounds with free binding energy ranging from -14.0 to -17.09 kcal mol<sup>-1</sup>
 were selected to check the hydrogen bond interaction with amino acid residues in the active site of 3CL<sup>pro</sup>
. Fifty-three compounds from 35 main groups were tested in an in vitro assay for inhibition of 3CL<sup>pro</sup>
 expressed by Escherichia coli. Seven of the 53 compounds were selected; their IC<sub>50</sub>
 ranged from 38.57 ± 2.41 to 101.38 ± 3.27 μM. Two strong 3CL<sup>pro</sup>
 inhibitors were further identified as competitive inhibitors of 3CL<sup>pro</sup>
 with K<sub>i</sub>
 values of 9.11 ± 1.6 and 9.93 ± 0.44 μM. Hydrophobic and hydrogen bond interactions of compound with amino acid residues in the active site of 3CL<sup>pro</sup>
 were also identified.</div>
</front>
</TEI>
<affiliations><list><country><li>Corée du Sud</li>
<li>France</li>
</country>
<region><li>Auvergne (région administrative)</li>
<li>Auvergne-Rhône-Alpes</li>
</region>
<settlement><li>Aubière</li>
</settlement>
</list>
<tree><country name="Corée du Sud"><noRegion><name sortKey="Nguyen, Thi Thanh Hanh" sort="Nguyen, Thi Thanh Hanh" uniqKey="Nguyen T" first="Thi Thanh Hanh" last="Nguyen">Thi Thanh Hanh Nguyen</name>
</noRegion>
<name sortKey="Hwang, Soonwook" sort="Hwang, Soonwook" uniqKey="Hwang S" first="Soonwook" last="Hwang">Soonwook Hwang</name>
<name sortKey="Joon Haeng Rhee" sort="Joon Haeng Rhee" uniqKey="Joon Haeng Rhee" last="Joon Haeng Rhee">JOON HAENG RHEE</name>
<name sortKey="Kim, Doman" sort="Kim, Doman" uniqKey="Kim D" first="Doman" last="Kim">Doman Kim</name>
<name sortKey="Lee, Se Hoon" sort="Lee, Se Hoon" uniqKey="Lee S" first="Se-Hoon" last="Lee">Se-Hoon Lee</name>
<name sortKey="Ryu, Hwa Ja" sort="Ryu, Hwa Ja" uniqKey="Ryu H" first="Hwa-Ja" last="Ryu">Hwa-Ja Ryu</name>
</country>
<country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Breton, Vincent" sort="Breton, Vincent" uniqKey="Breton V" first="Vincent" last="Breton">Vincent Breton</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002351 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002351 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:11-0474387
   |texte=   Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation

Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri